Prostate Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2021 to 2031

Jul 2021| FMR1265A| Fact Market Research

Report Highlights

Prostate Cancer Diagnostics Market- Scope of Report

A recent study by Fact.MR on the prostate cancer diagnostics market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering prostate cancer diagnostics.

The study also provides the dynamics responsible for influencing the future status of the prostate cancer diagnostics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the prostate cancer diagnostics market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of prostate cancer diagnostics products across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of prostate cancer diagnostics products during the forecast period. Price point comparison by region with global average price is also considered in the study.

Key Questions Answered in Report

  • Which are the most lucrative prostate cancer diagnostics markets?
  • Which factors will impact the growth of prostate cancer diagnostics?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the prostate cancer diagnostics industry?
  • What are the winning strategies of stakeholders in the market?

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Estimates at global and regional levels for prostate cancer diagnostics are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global prostate cancer diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of prostate cancer diagnostics during the forecast period.

Country-specific valuation on demand for prostate cancer diagnostics has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition Analysis

The report sheds light on leading providers of prostate cancer diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering prostate cancer diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the prostate cancer diagnostics domain. Prominent companies operating in this space include Abbott Laboratories, Biocept Inc., AstraZeneca Plc., Vyant Bio Inc., Danaher Corporation, Bayer Aktiengesellschaft, Becton, Dickinson and Company, Agilent Technologies, Foundation Medicine Inc. and Myriad Genetics Inc.

Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the prostate cancer diagnostics industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.

  • Table 1 : Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 22
  • Table 2 : Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2021-2031 23
  • Table 3 : Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 25
  • Table 4 : Global PSA Tests Segment Value (US$ Mn), By Region 2016-2020 27
  • Table 5 : Global PSA Tests Segment Value (US$ Mn), By Region 2021-2031 28
  • Table 6 : Global PSA Tests Segment Market Share, By Region 2016-2020 29
  • Table 7 : Global PSA Tests Segment Market Share, By Region 2021-2031 29
  • Table 8 : Global PSA Tests Segment Y-o-Y, By Region 2018-2031 29
  • Table 9 : Global CTC Tests Segment Value (US$ Mn), By Region 2016-2020 30
  • Table 10 : Global CTC Tests Segment Value (US$ Mn), By Region 2021-2031 31
  • Table 11 : Global CTC Tests Segment Market Share, By Region 2016-2020 32
  • Table 12 : Global CTC Tests Segment Market Share, By Region 2021-2031 32
  • Table 13 : Global CTC Tests Segment Y-o-Y, By Region 2018-2031 32
  • Table 14 : Global Immunohistochemistry Segment Value (US$ Mn), By Region 2016-2020 33
  • Table 15 : Global Immunohistochemistry Segment Value (US$ Mn), By Region 2021-2031 34
  • Table 16 : Global Immunohistochemistry Segment Market Share, By Region 2016-2020 35
  • Table 17 : Global Immunohistochemistry Segment Market Share, By Region 2021-2031 35
  • Table 18 : Global Immunohistochemistry Segment Y-o-Y, By Region 2018-2031 35
  • Table 19 : Global PCA3 test Segment Value (US$ Mn), By Region 2016-2020 36
  • Table 20 : Global PCA3 test Segment Value (US$ Mn), By Region 2021-2031 37
  • Table 21 : Global PCA3 test Segment Market Share, By Region 2016-2020 38
  • Table 22 : Global PCA3 test Segment Market Share, By Region 2021-2031 38
  • Table 23 : Global PCA3 test Segment Y-o-Y, By Region 2018-2031 38
  • Table 24 : Global Others Segment Value (US$ Mn), By Region 2016-2020 39
  • Table 25 : Global Others Segment Value (US$ Mn), By Region 2021-2031 40
  • Table 26 : Global Others Segment Market Share, By Region 2016-2020 41
  • Table 27 : Global Others Segment Market Share, By Region 2021-2031 41
  • Table 28 : Global Others Segment Y-o-Y, By Region 2018-2031 41
  • Table 29 : Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020 43
  • Table 30 : Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031 44
  • Table 31 : Global Hospital Associated Labs Segment Market Share, By Region 2016-2020 45
  • Table 32 : Global Hospital Associated Labs Segment Market Share, By Region 2021-2031 45
  • Table 33 : Global Hospital Associated Labs Segment Y-o-Y, By Region 2018-2031 45
  • Table 34 : Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020 46
  • Table 35 : Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031 47
  • Table 36 : Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020 48
  • Table 37 : Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031 48
  • Table 38 : Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2018-2031 48
  • Table 39 : Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020 49
  • Table 40 : Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031 50
  • Table 41 : Global Cancer Research Institutes Segment Market Share, By Region 2016-2020 51
  • Table 42 : Global Cancer Research Institutes Segment Market Share, By Region 2021-2031 51
  • Table 43 : Global Cancer Research Institutes Segment Y-o-Y, By Region 2018-2031 51
  • Table 44 : Global Others Segment Value (US$ Mn), By Region 2016-2020 52
  • Table 45 : Global Others Segment Value (US$ Mn), By Region 2021-2031 53
  • Table 46 : Global Others Segment Market Share, By Region 2016-2020 54
  • Table 47 : Global Others Segment Market Share, By Region 2021-2031 54
  • Table 48 : Global Others Segment Y-o-Y, By Region 2018-2031 54
  • Table 49 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 56
  • Table 50 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56
  • Table 51 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57
  • Table 52 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 58
  • Table 53 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 59
  • Table 54 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 60
  • Table 55 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 61
  • Table 56 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61
  • Table 57 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 63
  • Table 58 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 63
  • Table 59 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 64
  • Table 60 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 65
  • Table 61 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 66
  • Table 62 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 67
  • Table 63 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 68
  • Table 64 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 68
  • Table 65 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 69
  • Table 66 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 70
  • Table 67 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 71
  • Table 68 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 72
  • Table 69 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 73
  • Table 70 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 73
  • Table 71 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 74
  • Table 72 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 75
  • Table 73 : US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 77
  • Table 74 : US Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 77
  • Table 75 : US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 78
  • Table 76 : US Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 78
  • Table 77 : Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 79
  • Table 78 : Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 79
  • Table 79 : Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 80
  • Table 80 : Canada Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 80
  • Table 81 : Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 81
  • Table 82 : Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 81
  • Table 83 : Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 82
  • Table 84 : Brazil Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 82
  • Table 85 : Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 83
  • Table 86 : Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 83
  • Table 87 : Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 84
  • Table 88 : Mexico Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 84
  • Table 89 : Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 85
  • Table 90 : Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 85
  • Table 91 : Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 86
  • Table 92 : Argentina Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 86
  • Table 93 : Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 87
  • Table 94 : Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 87
  • Table 95 : Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 88
  • Table 96 : Germany Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 88
  • Table 97 : UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 89
  • Table 98 : UK Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 89
  • Table 99 : UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 90
  • Table 100 : UK Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 90
  • Table 101 : France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 91
  • Table 102 : France Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 91
  • Table 103 : France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 92
  • Table 104 : France Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 92
  • Table 105 : Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 93
  • Table 106 : Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 93
  • Table 107 : Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 94
  • Table 108 : Spain Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 94
  • Table 109 : Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 95
  • Table 110 : Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 95
  • Table 111 : Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 96
  • Table 112 : Italy Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 96
  • Table 113 : Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 97
  • Table 114 : Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 97
  • Table 115 : Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 98
  • Table 116 : Nordic Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 98
  • Table 117 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 99
  • Table 118 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 99
  • Table 119 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 100
  • Table 120 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 100
  • Table 121 : China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 101
  • Table 122 : China Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 101
  • Table 123 : China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 102
  • Table 124 : China Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 102
  • Table 125 : India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 103
  • Table 126 : India Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 103
  • Table 127 : India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 104
  • Table 128 : India Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 104
  • Table 129 : Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 105
  • Table 130 : Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 105
  • Table 131 : Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 106
  • Table 132 : Malaysia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 106
  • Table 133 : Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 107
  • Table 134 : Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 107
  • Table 135 : Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 108
  • Table 136 : Thailand Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 108
  • Table 137 : Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 109
  • Table 138 : Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 109
  • Table 139 : Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 110
  • Table 140 : Singapore Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 110
  • Table 141 : Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 111
  • Table 142 : Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 111
  • Table 143 : Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 112
  • Table 144 : Australia Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 112
  • Table 145 : GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 113
  • Table 146 : GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 113
  • Table 147 : GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 114
  • Table 148 : GCC Countries Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 114
  • Table 149 : South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 115
  • Table 150 : South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 115
  • Table 151 : South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 116
  • Table 152 : South Africa Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 116
  • Table 153 : Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 117
  • Table 154 : Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 117
  • Table 155 : Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 118
  • Table 156 : Nigeria Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 118
  • Table 157 : Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 119
  • Table 158 : Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 119
  • Table 159 : Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 120
  • Table 160 : Israel Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 120
  • Figure 1 : Global Prostate Cancer Diagnostics Market Value (US$ Mn), 2016-2020 15
  • Figure 2 : Global Prostate Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031 15
  • Figure 3 : Global Prostate Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2018-2031 17
  • Figure 4 : Global PSA Tests Segment Market Value (US$ Mn) By Region, 2016-2020 19
  • Figure 5 : Global PSA Tests Segment Market Value (US$ Mn) By Region, 2021-2031 20
  • Figure 6 : Global PSA Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 22
  • Figure 7 : Global CTC Tests Segment Market Value (US$ Mn) By Region, 2016-2020 22
  • Figure 8 : Global CTC Tests Segment Market Value (US$ Mn) By Region, 2021-2031 23
  • Figure 9 : Global CTC Tests Segment Y-o-Y Growth Rate, By Region, 2018-2031 25
  • Figure 10 : Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2016-2020 25
  • Figure 11 : Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2021-2031 26
  • Figure 12 : Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2018-2031 28
  • Figure 13 : Global PCA3 test Segment Market Value (US$ Mn) By Region, 2016-2020 28
  • Figure 14 : Global PCA3 test Segment Market Value (US$ Mn) By Region, 2021-2031 29
  • Figure 15 : Global PCA3 test Segment Y-o-Y Growth Rate, By Region, 2018-2031 31
  • Figure 16 : Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 31
  • Figure 17 : Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 32
  • Figure 18 : Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 34
  • Figure 19 : Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020 35
  • Figure 20 : Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031 36
  • Figure 21 : Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2018-2031 38
  • Figure 22 : Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020 38
  • Figure 23 : Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031 39
  • Figure 24 : Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2018-2031 41
  • Figure 25 : Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020 41
  • Figure 26 : Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031 42
  • Figure 27 : Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2018-2031 44
  • Figure 28 : Global Others Segment Market Value (US$ Mn) By Region, 2016-2020 44
  • Figure 29 : Global Others Segment Market Value (US$ Mn) By Region, 2021-2031 45
  • Figure 30 : Global Others Segment Y-o-Y Growth Rate, By Region, 2018-2031 47
  • Figure 31 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 48
  • Figure 32 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 49
  • Figure 33 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 50
  • Figure 34 : North America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 50
  • Figure 35 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 51
  • Figure 36 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 52
  • Figure 37 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 53
  • Figure 38 : Latin America Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 54
  • Figure 39 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 55
  • Figure 40 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 56
  • Figure 41 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 57
  • Figure 42 : Europe Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 57
  • Figure 43 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 58
  • Figure 44 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 59
  • Figure 45 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 60
  • Figure 46 : Japan Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 61
  • Figure 47 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 62
  • Figure 48 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 62
  • Figure 49 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 63
  • Figure 50 : APEJ Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 64
  • Figure 51 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020 65
  • Figure 52 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031 66
  • Figure 53 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020 67
  • Figure 54 : MEA Prostate Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031 67

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report